Bono; Francoise

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bono; Francoise.The latest application filed is for "novel (heterocycle/condensed piperidine)-(piperazinyl)-1-alkanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alkanone derivatives and use thereof as p75 inhibitors".

Company Profile

0.26.21

Bono; Francoise - Paris N/A FR
Bono; Francoise - Toulouse FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
FGF-receptor agonist dimeric compounds Grant 9,120,819 - Bono , et al. September 1, 2	2015-09-01
(Heterocycle/condensed piperidine)-(piperazinyl)-1-alkanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alkanone derivatives and use thereof as p75 inhibitors Grant 8,957,211 - Baroni , et al. February 17, 2	2015-02-17
(heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors Grant 8,906,924 - Baroni , et al. December 9, 2	2014-12-09
NOVEL (HETEROCYCLE/CONDENSED PIPERIDINE)-(PIPERAZINYL)-1-ALKANONE OR (HETEROCYCLE/CONDENSED PYRROLIDINE)-(PIPERAZINYL)-1-ALKANONE DERIVATIVES AND USE THEREOF AS p75 INHIBITORS App 20140038946 - BARONI; Marco ; et al.	2014-02-06
Imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same Grant 8,633,216 - Alcouffe , et al. January 21, 2	2014-01-21
Derivatives of 7 alkynyl-1,8 naphthyridones, preparation method thereof and use of same in therapeutics Grant 8,586,602 - Alam , et al. November 19, 2	2013-11-19
NOVEL (HETEROCYCLE/TETRAHYDROPYRIDINE)-(PIPERAZINYL)-1-ALCANONE AND (HETEROCYCLE/DIHYDROPYRROLIDINE)-(PIPERAZINYL)-1-ALCANONE DERIVATIVES, AND USE THEREOF AS p75 INHIBITORS App 20130303520 - BARONI; Marco ; et al.	2013-11-14
(Heterocycle/condensed piperidine)-(piperazinyl)-1-alkanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alkanone derivatives and use thereof as p75 inhibitors Grant 8,580,790 - Baroni , et al. November 12, 2	2013-11-12
Derivatives of (bridged piperazinyl)-1-alkanone and use thereof as p75 inhibitors Grant 8,519,143 - Baroni , et al. August 27, 2	2013-08-27
(Heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors Grant 8,518,947 - Baroni , et al. August 27, 2	2013-08-27
Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics Grant 8,470,847 - Alam , et al. June 25, 2	2013-06-25
Derivatives Of 2-oxoalkyl-1-piperazin-2-one, Preparation Method Thereof And Therapeutic Use Of Same App 20120289518 - BARONI; Marco ; et al.	2012-11-15
NOVEL (HETEROCYCLE/CONDENSED PIPERIDINE)-(PIPERAZINYL)-1-ALKANONE OR (HETEROCYCLE/CONDENSED PYRROLIDINE)-(PIPERAZINYL)-1-ALKANONE DERIVATIVES AND USE THEREOF AS p75 INHIBITORS App 20120245149 - BARONI; Marco ; et al.	2012-09-27
NOVEL (HETEROCYCLE/TETRAHYDROPYRIDINE)-(PIPERAZINYL)-1-ALCANONE AND (HETEROCYCLE/DIHYDROPYRROLIDINE)-(PIPERAZINYL)-1-ALCANONE DERIVATIVES, AND USE THEREOF AS p75 INHIBITORS App 20120245150 - BARONI; Marco ; et al.	2012-09-27
Derivatives Of 7 Alkynyl-1,8 Naphthyridones, Preparation Method Thereof And Use Of Same In Therapeutics App 20120238598 - ALAM; Antoine ; et al.	2012-09-20
DERIVATIVES OF (BRIDGED PIPERAZINYL)-1-ALKANONE AND USE THEREOF AS p75 INHIBITORS App 20120232280 - BARONI; Marco ; et al.	2012-09-13
Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics Grant 8,263,614 - Alam , et al. September 11, 2	2012-09-11
Derivatives of 2-oxoalkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same Grant 8,247,404 - Baroni , et al. August 21, 2	2012-08-21
Derivatives of (bridged piperazinyl)-1-alkanone and use thereof as p75 inhibitors Grant 8,193,190 - Baroni , et al. June 5, 2	2012-06-05
Use of FGF inhibiting substituted 1,2,3 indolizine derivatives in the preparation of medicaments which can be used to treat diseases linked to pathological choroidal angiogenesis Grant 8,034,828 - Badorc , et al. October 11, 2	2011-10-11
Imidazo[1,5-a] pyridine derivatives, method for preparing same and pharmaceutical compositions containing same Grant 8,008,321 - Alcouffe , et al. August 30, 2	2011-08-30
Fgf-r4 Receptor-specific Antagonists App 20110150903 - Baurin; Nicolas ; et al.	2011-06-23
Derivatives Of 2-oxoalkyl-1-piperazin-2-one, Preparation Method Thereof And Therapeutic Use Of Same App 20110144122 - BARONI; Marco ; et al.	2011-06-16
DERIVATIVES OF (BRIDGED PIPERAZINYL)-1-ALKANONE AND USE THEREOF AS p75 INHIBITORS App 20110144116 - BARONI; Marco ; et al.	2011-06-16
Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same App 20110136856 - ALCOUFFE; Chantal ; et al.	2011-06-09
1,2,3-substituted indolizine derivatives, inhibitors of FGFs, method for preparing them and pharmaceutical compositions containing them Grant 7,803,811 - Badorc , et al. September 28, 2	2010-09-28
Derivatives Of 7-alkynyl-1,8-naphthyridones, Preparation Method Thereof And Use Of Same In Therapeutics App 20100144757 - ALAM; Antoine ; et al.	2010-06-10
Derivatives Of 7-alkynyl-1,8-naphthyridones, Preparation Method Thereof And Use Of Same In Therapeutics App 20100144782 - ALAM; Antoine ; et al.	2010-06-10
Substituted indolizine 1,2,3,6,7,8 derivatives, FGFs inhibitors, a method for the preparation thereof and pharmaceutical compositions containing said derivatives Grant 7,553,845 - Alcouffe , et al. June 30, 2	2009-06-30
Fgf-receptor Agonist Dimeric Compounds App 20090069368 - BONO; Francoise ; et al.	2009-03-12
Use Of Fgf Inhibiting Substituted 1,2,3 Indolizine Derivatives In The Preparation Of Medicaments Which Can Be Used To Treat Diseases Linked To Pathological Choroidal Angiogenesis App 20090030034 - BADORC; Alain ; et al.	2009-01-29
Novel 1,2,3-Substituted Indolizine Derivatives, Inhibitors of FGFs, Method for Preparing Them and Pharmaceutical Compositions Containing Them App 20090023770 - BADORC; Alain ; et al.	2009-01-22
Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof Grant 7,468,368 - Bono , et al. December 23, 2	2008-12-23
1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same Grant 7,442,708 - Badorc , et al. October 28, 2	2008-10-28
Novel imidazo[1,5-a] pyridine derivatives, method for preparing same and pharmaceutical compositions containing same App 20080108648 - ALCOUFFE; Chantal ; et al.	2008-05-08
Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof Grant 7,294,628 - Bono , et al. November 13, 2	2007-11-13
Substituted indolizine 1,2,3,6,7,8 derivatives, FGFs inhibitors, a method for the preparation thereof and pharmaceutical compositions containing said derivatives App 20060199962 - Alcouffe; Chantal ; et al.	2006-09-07
Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof App 20060167007 - Bono; Francoise ; et al.	2006-07-27
Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same App 20050203126 - Badorc, Alain ; et al.	2005-09-15
Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof App 20050176722 - Bono, Francoise ; et al.	2005-08-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.